ZYNEX INC Files Definitive Proxy Statement (DEF 14A)

Ticker: ZYXIQ · Form: DEF 14A · Filed: Apr 1, 2024 · CIK: 846475

Zynex Inc DEF 14A Filing Summary
FieldDetail
CompanyZynex Inc (ZYXIQ)
Form TypeDEF 14A
Filed DateApr 1, 2024
Risk Levellow
Pages16
Reading Time19 min
Key Dollar Amounts$800 million, $2 billion, $250 million
Sentimentneutral

Sentiment: neutral

Topics: DEF 14A, Proxy Statement, ZYNEX INC, Executive Compensation, Equity Awards

TL;DR

<b>ZYNEX INC has filed its Definitive Proxy Statement (DEF 14A) for the fiscal year ending December 31, 2023, detailing executive compensation and equity awards.</b>

AI Summary

ZYNEX INC (ZYXIQ) filed a Proxy Statement (DEF 14A) with the SEC on April 1, 2024. ZYNEX INC filed a Definitive Proxy Statement (DEF 14A) on April 1, 2024. The filing pertains to the fiscal year ending December 31, 2023. The company's principal executive offices are located at 9655 Maroon Circle, Englewood, CO 80112. ZYNEX INC was formerly known as ZYNEX MEDICAL HOLDINGS INC and FOX RIVER HOLDINGS INC. The filing includes data related to equity awards and compensation for PEO and Non-PEO members for fiscal years 2022 and 2023.

Why It Matters

For investors and stakeholders tracking ZYNEX INC, this filing contains several important signals. This DEF 14A filing is crucial for shareholders as it outlines proposals to be voted on at the annual meeting, including the election of directors and executive compensation matters. Understanding the details of equity awards and compensation changes for PEO and Non-PEO members provides insight into management's incentives and the company's financial strategy.

Risk Assessment

Risk Level: low — ZYNEX INC shows low risk based on this filing. The filing is a routine DEF 14A, which is standard for publicly traded companies and does not indicate any immediate financial or operational distress.

Analyst Insight

Shareholders should review the proxy statement to understand executive compensation structures and vote on relevant proposals at the upcoming annual meeting.

Key Numbers

  • 2023-12-31 — Fiscal Year End (Fiscal year end date)
  • 2022-12-31 — Prior Fiscal Year End (Prior fiscal year end date)
  • 2021-12-31 — Prior Fiscal Year End (Prior fiscal year end date)
  • 2020-12-31 — Prior Fiscal Year End (Prior fiscal year end date)

Key Players & Entities

  • ZYNEX INC (company) — Filer name
  • DEF 14A (filing) — Form type
  • 2024-04-01 (date) — Filing date
  • 2024-05-16 (date) — Period of report
  • 0000846475 (company) — Central Index Key
  • 3845 (industry) — Standard Industrial Classification
  • NV (state) — State of incorporation
  • 9655 Maroon Circle, Englewood, CO 80112 (address) — Business address

FAQ

When did ZYNEX INC file this DEF 14A?

ZYNEX INC filed this Proxy Statement (DEF 14A) with the SEC on April 1, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by ZYNEX INC (ZYXIQ).

Where can I read the original DEF 14A filing from ZYNEX INC?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by ZYNEX INC.

What are the key takeaways from ZYNEX INC's DEF 14A?

ZYNEX INC filed this DEF 14A on April 1, 2024. Key takeaways: ZYNEX INC filed a Definitive Proxy Statement (DEF 14A) on April 1, 2024.. The filing pertains to the fiscal year ending December 31, 2023.. The company's principal executive offices are located at 9655 Maroon Circle, Englewood, CO 80112..

Is ZYNEX INC a risky investment based on this filing?

Based on this DEF 14A, ZYNEX INC presents a relatively low-risk profile. The filing is a routine DEF 14A, which is standard for publicly traded companies and does not indicate any immediate financial or operational distress.

What should investors do after reading ZYNEX INC's DEF 14A?

Shareholders should review the proxy statement to understand executive compensation structures and vote on relevant proposals at the upcoming annual meeting. The overall sentiment from this filing is neutral.

How does ZYNEX INC compare to its industry peers?

ZYNEX INC operates in the electromedical and electrotherapeutic apparatus industry.

Are there regulatory concerns for ZYNEX INC?

The filing is a DEF 14A, which is a standard SEC filing for companies seeking shareholder votes on corporate matters.

Industry Context

ZYNEX INC operates in the electromedical and electrotherapeutic apparatus industry.

Regulatory Implications

The filing is a DEF 14A, which is a standard SEC filing for companies seeking shareholder votes on corporate matters.

What Investors Should Do

  1. Review the detailed executive compensation tables for PEO and Non-PEO members.
  2. Analyze the changes in fair value of equity awards granted in current and prior fiscal years.
  3. Understand the proposals to be voted on at the annual shareholder meeting.

Year-Over-Year Comparison

This filing is a DEF 14A, which is a routine disclosure and does not represent a change from previous filings in terms of the type of document submitted.

Filing Stats: 4,737 words · 19 min read · ~16 pages · Grade level 12.8 · Accepted 2024-04-01 16:54:31

Key Financial Figures

  • $800 million — pid Sciences, Inc. He has raised nearly $800 million in capital within public and private ma
  • $2 billion — ncreased shareholder value by more than $2 billion. Mr. Michaels holds a BA in Audiology a
  • $250 million — on stage and grew product sales to over $250 million. Mr. Disbrow exited Arbor upon the comp

Filing Documents

From the Filing

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 Filed by the Registrant Filed by a Party other than the Registrant Check the appropriate box: Preliminary Proxy Statement Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2)) Definitive Proxy Statement Definitive Additional Materials Soliciting Material Pursuant to 240.14a-12 ZYNEX, INC. (Name of Registrant as Specified In Its Charter) (Name of Person(s) Filing Proxy Statement, if other than the Registrant) Payment of Filing Fee (Check the appropriate box): No fee required. Fee paid previously with preliminary materials. Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and 0-11. Persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. April 1, 2024 Dear Stockholder, I am pleased to extend this invitation to attend the 2024 Annual Meeting of Stockholders (the "Annual Meeting") of Zynex, Inc. to be held at 9:00 a.m., local time, on May 16, 2024, at the Company's corporate headquarters at 9655 Maroon Circle, Englewood, Colorado 80112. The attached notice of Annual Meeting and proxy statement describe the matters to be presented at the Annual Meeting and provide information about us that you should consider when you vote your shares. The principal business of the meeting will be (i) to elect as directors the nominees named in the proxy statement to serve until the 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified or until the earlier of their resignation or removal, (ii) to ratify the selection of Marcum LLP as our independent public accountant for the fiscal year ending December 31, 2024, and (iii) to consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof. We hope you will be able to attend the Annual Meeting. Whether you plan to attend the Annual Meeting or not, it is important that your shares are represented. Therefore, when you have finished reading the proxy statement, you are urged to complete, sign, date and return the enclosed proxy card, or respond via Internet or telephone, promptly in accordance with the instructions set forth on the proxy card. This will ensure your proper representation at the Annual Meeting, whether or not you can attend. Best regards, Thomas Sandgaard Chairman, President and Chief Executive Officer NOTICE OF ANNUAL MEETING OF STOCKHOLDERS TO BE HELD ON MAY 16, 2024 To the Stockholders of Zynex, Inc.: You are invited to attend the Annual Meeting of Stockholders of Zynex, Inc. which will be held at 9:00 a.m. local time at 9655 Maroon Circle, Englewood, Colorado 80112, on Thursday, May 16, 2024. At the Annual Meeting, you will be asked to act on the following matters: 1. to elect as directors the four nominees named in the Proxy Statement as directors; 2. to ratify the selection of Marcum LLP as our independent registered public accounting firm to audit the consolidated financial statements of Zynex, Inc. for our fiscal year ending December 31, 2024; and 3. to consider and transact such other business as may be properly brought before the Annual Meeting and any adjournments thereof. The Proxy Statement accompanying this Notice describes these items more fully. Only holders of record of shares of our common stock at the close of business on March 19, 2024 are entitled to vote at the Annual Meeting or any postponements or adjournments of the meeting. YOUR VOTE IS IMPORTANT. PLEASE READ THE PROXY STATEMENT AND VOTE BY FOLLOWING THE VOTING INSTRUCTIONS SENT TO YOU. Dated: April 1, 2024 By Order of the Board of Directors of Zynex, Inc. Sincerely, Thomas Sandgaard Chairman, President, and Chief Executive Officer 9655 Maroon Circle Englewood, Colorado 80112 PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS MAY 16, 2024 This proxy statement contains information related to the Annual Meeting of Stockholders of Zynex, Inc. which will be held at 9:00 a.m. local time at 9655 Maroon Circle, Englewood, Colorado 80112, on Thursday, May 16, 2024, and any postponements or adjournments of the meeting. We first mailed, or made available on the Internet, these proxy materials to stockholders on or about April 1, 2024. In this proxy statement, "Company," "Zynex," "we," "us," and "our" each refer to Zynex, Inc. and its subsidiaries. ABOUT THE PROXY MATERIALS We are furnishing proxy materials to our stockholders primarily via the Internet, instead of mailing printed copies of those materials to each stockholder. By doing so, we save costs and reduce the environmental impact of our Annual Meeting. This proxy is being solicited by the Board of Directors, and the cost of solic

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.